ZA964210B - Polymyxin conjugates. - Google Patents

Polymyxin conjugates.

Info

Publication number
ZA964210B
ZA964210B ZA9604210A ZA964210A ZA964210B ZA 964210 B ZA964210 B ZA 964210B ZA 9604210 A ZA9604210 A ZA 9604210A ZA 964210 A ZA964210 A ZA 964210A ZA 964210 B ZA964210 B ZA 964210B
Authority
ZA
South Africa
Prior art keywords
polymyxin
conjugates
polymyxin conjugates
Prior art date
Application number
ZA9604210A
Other languages
English (en)
Inventor
Prasad Koteswara Kapa
Andrew Kucerovy
Paul Gerard Mattner
Mahavir Prashad
Gleb Kardash
Philip Lake
Russell C Petter
Sushil Sharma
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA964210B publication Critical patent/ZA964210B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA9604210A 1995-05-25 1996-05-24 Polymyxin conjugates. ZA964210B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/449,436 US5691304A (en) 1995-05-25 1995-05-25 Improved process for preparing polymyxin B/dextran conjugates

Publications (1)

Publication Number Publication Date
ZA964210B true ZA964210B (en) 1997-11-24

Family

ID=23784156

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604210A ZA964210B (en) 1995-05-25 1996-05-24 Polymyxin conjugates.

Country Status (24)

Country Link
US (1) US5691304A (cs)
EP (1) EP0830147A1 (cs)
JP (1) JPH11505216A (cs)
KR (1) KR19990021926A (cs)
CN (1) CN1185115A (cs)
AR (1) AR004488A1 (cs)
AU (1) AU711200B2 (cs)
BR (1) BR9609130A (cs)
CA (1) CA2219778A1 (cs)
CO (1) CO4700478A1 (cs)
CZ (1) CZ288830B6 (cs)
FI (1) FI974004A7 (cs)
HU (1) HUP9801750A3 (cs)
IL (1) IL118407A (cs)
NO (1) NO975329L (cs)
NZ (1) NZ309764A (cs)
PE (1) PE5398A1 (cs)
PL (1) PL323186A1 (cs)
RU (1) RU2164149C2 (cs)
SK (1) SK157997A3 (cs)
TR (1) TR199701426T1 (cs)
TW (1) TW426517B (cs)
WO (1) WO1996037233A1 (cs)
ZA (1) ZA964210B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006419A1 (en) * 1996-08-15 1998-02-19 Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
RU2283848C1 (ru) * 2005-06-16 2006-09-20 Институт нефтехимии и катализа РАН Республика Башкортостан Способ получения конъюгатов альгиновой кислоты
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US9161962B2 (en) 2010-11-01 2015-10-20 Nanoderm Sciences, Inc. Targeted therapeutic nanoparticles
US20180028684A1 (en) 2010-11-01 2018-02-01 Nanoderm Sciences, Inc. Targeted nanoparticles
EP2872120B1 (en) * 2012-07-16 2017-05-03 Nanoderm Sciences, Inc. Therapeutic nanoparticles with a polymyxin b as targeting agent
CN115321819B (zh) * 2022-08-15 2024-02-13 希诺股份有限公司 一种高钢化抗菌玻璃杯及其制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7702261L (sv) * 1976-03-02 1977-09-07 Pharmaco Inc Forfarande for att immobilisera antimikrobiella emnen
MY104520A (en) * 1989-11-15 1994-04-30 Novartis Ag Polymyxin conjugates.
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates

Also Published As

Publication number Publication date
US5691304A (en) 1997-11-25
IL118407A (en) 2000-10-31
TR199701426T1 (xx) 1998-02-21
BR9609130A (pt) 1999-02-23
FI974004L (fi) 1997-11-25
IL118407A0 (en) 1996-09-12
CZ372197A3 (cs) 1998-03-18
RU2164149C2 (ru) 2001-03-20
EP0830147A1 (en) 1998-03-25
AU711200B2 (en) 1999-10-07
JPH11505216A (ja) 1999-05-18
MX9709003A (es) 1998-03-31
CZ288830B6 (cs) 2001-09-12
KR19990021926A (ko) 1999-03-25
CN1185115A (zh) 1998-06-17
WO1996037233A1 (en) 1996-11-28
AR004488A1 (es) 1998-12-16
HUP9801750A2 (hu) 1998-11-30
CO4700478A1 (es) 1998-12-29
PL323186A1 (en) 1998-03-16
PE5398A1 (es) 1998-02-16
AU6000796A (en) 1996-12-11
FI974004A7 (fi) 1997-11-25
NO975329D0 (no) 1997-11-20
NO975329L (no) 1997-11-20
FI974004A0 (fi) 1997-10-20
SK157997A3 (en) 1998-04-08
TW426517B (en) 2001-03-21
HUP9801750A3 (en) 1998-12-28
NZ309764A (en) 1999-04-29
CA2219778A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA981926B (en) Detergent--package combination.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA964210B (en) Polymyxin conjugates.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
EP0672364A3 (de) Skischuh.
ZA967314B (en) Carbamoylcarboxamides.
GR3034943T3 (en) Medrogestrone.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
EP0671133A3 (de) Skischuh.
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
ZA98263B (en) O-fucosyltransferase.
ZA983698B (en) Estrenes.
ZA9811834B (en) Substititued ß-alanines.